RÉSUMÉ
A complex series of studies by Oelschlegel et al. in a murine model of cerebral malaria establishes a temporal sequence of events linking decreased venous efflux to impaired perfusion, edema, and neuroinflammation. The relevance to human cerebral malaria is discussed, including the heterogeneity recognized in recent investigations of cerebrovascular hemodynamics.
Sujet(s)
Oedème cérébral , Modèles animaux de maladie humaine , Paludisme cérébral , Paludisme cérébral/physiopathologie , Paludisme cérébral/parasitologie , Animaux , Souris , Oedème cérébral/parasitologie , HumainsRÉSUMÉ
Cerebral malaria (CM) is a life-threatening complication of Plasmodium falciparum malaria that continues to be a major global health problem. Brain vascular dysfunction is a main factor underlying the pathogenesis of CM and can be a target for the development of adjuvant therapies for the disease. Vascular occlusion by parasitised red blood cells and vasoconstriction/vascular dysfunction results in impaired cerebral blood flow, ischaemia, hypoxia, acidosis and death. In this review, we discuss the mechanisms of vascular dysfunction in CM and the roles of low nitric oxide bioavailability, high levels of endothelin-1 and dysfunction of the angiopoietin-Tie2 axis. We also discuss the usefulness and relevance of the murine experimental model of CM by Plasmodium berghei ANKA to identify mechanisms of disease and to screen potential therapeutic interventions.
Sujet(s)
Animaux , Humains , Souris , Érythrocytes/parasitologie , Paludisme cérébral/physiopathologie , /métabolisme , Barrière hémato-encéphalique/parasitologie , Circulation cérébrovasculaire , Modèles animaux de maladie humaine , Endothélines/métabolisme , Interactions hôte-parasite , Paludisme cérébral/parasitologie , Monoxyde d'azote/métabolisme , Vasoconstriction/physiologieRÉSUMÉ
La malaria cerebral es una de las complicaciones más importantes de la infección con Plasmodium falciparum. El 40% de la población mundial vive en áreas afectadas por la malaria, lo que ha resultado en aproximadamente 243 millones de casos clínicos y 863000 muertes en el 2008, la mayoría en niños menores de 5 años del África subsahariana. La malaria cerebral presenta un gran desafío en el esclarecimiento de su fisiopatología. Aunque no existe un modelo experimental que reproduzca todos los aspectos de la enfermedad en humanos, los modelos murinos han sido el instrumento más provechoso, entre ellos la infección de hospederos susceptibles con la cepa ANKA de Plasmodium berghei es el más generalizado. Los estudios de patogenia de la malaria cerebral experimental están fundamentados por más de 20 años de investigación. Este trabajo revisa los hallazgos recientes y selecciona los elementos cardinales que sustentan la relevancia y operatividad de estos modelos. Concluye que la caracterización conductual precisa y la descripción de los cambios histológicos, metabólicos e inmunológicos concomitantes en los modelos actuales pueden ser herramientas útiles para investigar las dianas y la efectividad de futuras intervenciones terapéuticas
Cerebral malaria is one of the most important complications of Plasmodium falciparum infections. Forty percent of the worldwide population is at risk of being infected of malaria. These infections produced approximately 243 millions of clinical cases and 863000 deaths in 2008, the majority of them are children under 5 years old from sub-Saharan Africa. Knowledge of the pathophysiology of cerebral malaria is a big task. At present, no model is capable to reproduce all aspects of the human disease, but murine models have been helpful tools. Among them, infection of susceptible hosts with the strain ANKA of Plasmodium berghei is the most widely used. Studies of experimental cerebral malaria are based on more than 20 years of research. This work reviewed the recent findings and selected the cardinal elements that support the relevance and operative performance of these models. In summary, it concludes that the use of precise behavioural characterization and description of concomitant histological, metabolic and immunological changes of existing models can become means for successful research on targets and efficacy of future therapeutic interventions.
Sujet(s)
Antipaludiques , Paludisme cérébral/physiopathologie , Plasmodium bergheiSujet(s)
Humains , Femelle , Adulte d'âge moyen , Paludisme cérébral/complications , Paludisme cérébral/diagnostic , Arrêt cardiaque/complications , Arrêt cardiaque hors hôpital/complications , Arrêt cardiaque hors hôpital/diagnostic , Soins de santé primaires/méthodes , Soins de santé primaires/tendances , Doxycycline/usage thérapeutique , Paludisme/traitement médicamenteux , Paludisme cérébral/physiopathologie , Paludisme cérébral , Arrêt cardiaque/physiopathologie , Arrêt cardiaque , Arrêt cardiaque hors hôpital/physiopathologie , Arrêt cardiaque hors hôpital , Plasmodium falciparum/pathogénicité , Paludisme à Plasmodium falciparum/mortalité , Lombalgie/complicationsRÉSUMÉ
Cerebral malaria (CM) is a severe complication resulting from Plasmodium falciparum infection. This condition has been associated with cognitive, behavioral and motor dysfunctions, seizures and coma. The underlying mechanisms of CM are incompletely understood. Glutamate and other metabolites such as lactate have been implicated in its pathogenesis. In the present study, we investigated the involvement of glutamate in the behavioral symptoms of CM. Seventeen female C57BL/6 mice (20-25 g) aged 6-8 weeks were infected with P. berghei ANKA by the intraperitoneal route using a standardized inoculation of 10(6) parasitized red blood cells suspended in 0.2 mL PBS. Control animals (N = 17) received the same volume of PBS. Behavioral and neurological symptoms were analyzed by the SmithKline/Harwell/Imperial College/Royal Hospital/Phenotype Assessment (SHIRPA) battery. Glutamate release was measured in the cerebral cortex and cerebrospinal fluid of infected and control mice by fluorimetric assay. All functional categories of the SHIRPA battery were significantly altered in the infected mice at 6 days post-infection (dpi) (P ≤ 0.05). In parallel to CM symptoms, we found a significant increase in glutamate levels in the cerebral cortex (mean ± SEM; control: 11.62 ± 0.90 nmol/mg protein; infected at 3 dpi: 10.36 ± 1.17 nmol/mg protein; infected at 6 dpi: 26.65 ± 0.73 nmol/mg protein; with EGTA, control: 5.60 ± 1.92 nmol/mg protein; infected at 3 dpi: 6.24 ± 1.87 nmol/mg protein; infected at 6 dpi: 14.14 ± 0.84 nmol/mg protein) and in the cerebrospinal fluid (control: 128 ± 51.23 pmol/mg protein; infected: 301.4 ± 22.52 pmol/mg protein) of infected mice (P ≤ 0.05). These findings suggest a role of glutamate in the central nervous system dysfunction found in CM.
Sujet(s)
Animaux , Femelle , Souris , Symptômes comportementaux/physiopathologie , Cortex cérébral/composition chimique , Liquide cérébrospinal/composition chimique , Acide glutamique/métabolisme , Paludisme cérébral/métabolisme , Plasmodium berghei , Paludisme cérébral/liquide cérébrospinal , Paludisme cérébral/physiopathologieRÉSUMÉ
A malária é a principal e a mais grave doença parasitária no mundo. A infecção pelo Plasmodium falciparum é capaz de afetar diretamente o sistema nervoso central, causando déficits cognitivos e comportamentais que caracterizam a malária cerebral (MC). A MC é uma complicação decorrente da malária grave sendo responsável pela maioria dos casos de incapacidade e óbito. A ocorrência de seqüelas cognitivas e comportamentais após tratamento da MC tem sido descrita, principalmente em crianças. Adultos e crianças apresentam diferenças nas manifestações clínicas resultantes da MC. Geralmente, as crianças cursam com um espectro maior de alterações e apresentam déficits em vários domínios cognitivos após o tratamento da doença. Apesar da sua relevância clínica, os mecanismos patogênicos envolvidos no desenvolvimento das seqüelas resultantes da MC permanecem pouco elucidados. O entendimento desses mecanismos é fundamental para elaboração de intervenções terapêuticas adequadas que atuem na prevenção desses transtornos.
Malaria is the main and most serious parasitic disease in the world. Plasmodium falciparum infection can affect directly the central nervoussystem leading to cognitive and behavioral impairment which characterize cerebral malaria (CM). CM is a complication of severe malaria beingresponsible for almost all disability and death. The occurrence of cognitive and behavioral impairment after treatment has been reported, especially in children. Adults and children have differences in clinical manifestations related to CM. In general, children tend to present a greater spectrum of symptoms and impairment in almost all domains of cognition after infection treatment. Despite of its clinical relevance, pathogenic mechanisms involved in the development of CM sequelae remain poorly understood. A better understanding of these mechanisms is essential for the elaboration of appropriate therapeutic interventions which may contribute to the prevention of CM sequelae.
Sujet(s)
Humains , Enfant , Adulte , Maladies du motoneurone/étiologie , Encéphalopathies/étiologie , Paludisme cérébral/complications , Paludisme cérébral/diagnostic , Paludisme cérébral/physiopathologie , Maladies parasitaires , Plasmodium falciparum/pathogénicité , Troubles de la cognition/étiologieRÉSUMÉ
Malaria is a parasitic disease with high prevalence in several regions of the world. Infestation by Plasmodium faciparum can, in some cases, affect the central nervous system producing encephalitis resulting in death or neurological sequelae. The mechanisms involved in the pathophysiology of the cerebral lesion are not totally clear and there are currently two theories (mechanical and humoral) concerning this. We report a case of malaria with an atypical evolution, with a stroke lesion in the territory of the middle cerebral artery, with no association with encephalitis. We conclude that the mechanical theory is the one applicable to this patient